Talaris Therapeutics to Participate at Three Upcoming Virtual Investor Conferences

Rhea-AI Summary

Talaris Therapeutics (Nasdaq: TALS) announced participation in key investor conferences aimed at showcasing its innovative therapies for solid organ transplantation and severe autoimmune diseases. Key events include the Virtual Guggenheim 3rd Annual Neuro/Immunology Conference on Nov 15-16, 2021, the Stifel 2021 Virtual Healthcare Conference on Nov 15, 2021, at 11:20 a.m. ET, and the Evercore ISI 4th Annual HealthCONx Virtual Conference with a fireside chat on Dec 1, 2021, at 4:20 p.m. ET. Live webcasts will be available on the Talaris website.

BOSTON and LOUISVILLE, Ky., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases, and certain severe non-malignant blood, immune and metabolic disorders, today announced that members of its senior management team will participate at the following investor conferences:

Virtual Guggenheim 3rd Annual Neuro/Immunology Conference

Dates: November 15-16, 2021

1x1 meetings only

Stifel 2021 Virtual Healthcare Conference

Presentation date: Monday, November 15, 2021

Presentation time: 11:20 a.m. ET

Evercore ISI 4th Annual HealthCONx Virtual Conference

Fireside Chat Date: Wednesday, December 1, 2021

Fireside Chat Time: 4:20 p.m. ET

A live webcast of the presentation at the Stifel 2021 Virtual Healthcare Conference and the fireside chat at the Evercore ISI 4th Annual HealthCONx Virtual Conference will be available on the investors section of the Talaris website at www.talaristx.com. After the live webcast, a replay of the events can be found on the Talaris website.

About Talaris Therapeutics
Talaris Therapeutics, Inc. is a late-clinical stage biopharmaceutical company developing investigational, one-time, allogeneic cell therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases, and certain severe non-malignant blood, immune and metabolic disorders. Talaris maintains corporate offices in Boston, MA, and its cell processing facility in Louisville, KY. For additional information, visit talaristx.com, and follow Talaris on Twitter, LinkedIn and Facebook.

Media Contact
Lisa Raffensperger
Ten Bridge Communications
lisa@tenbridgecommunications.com
(617) 903-8783

Investor Contact
Chris Brinzey
ICR Westwicke
chris.brinzey@westwicke.com
(339) 970-2843

FAQ

What is Talaris Therapeutics participating in on November 15-16, 2021?

Talaris Therapeutics is participating in the Virtual Guggenheim 3rd Annual Neuro/Immunology Conference on November 15-16, 2021.

When is the Stifel 2021 Virtual Healthcare Conference presentation scheduled?

The presentation at the Stifel 2021 Virtual Healthcare Conference is scheduled for November 15, 2021, at 11:20 a.m. ET.

What is the date and time for the Talaris fireside chat at Evercore ISI 4th Annual HealthCONx Virtual Conference?

The fireside chat will take place on December 1, 2021, at 4:20 p.m. ET during the Evercore ISI 4th Annual HealthCONx Virtual Conference.

Where can I find the live webcast for Talaris presentations?

Live webcasts of Talaris presentations will be available on the investors section of the Talaris website.